Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA.

Image 0 of Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA.Image 1 of Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA.Image 2 of Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA.

Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA.

CALL US FOR THE PRICE

Flexeril 5mg Tablets 1X100 each Mfg.by: J O M Pharmaceutical Services USA. This item requires a valid order from a physician licensed in the USA. Item No.:RXD3468436/RXB10046727 NDC No.: 50580-0280-10 Category: Cyclobenzaprine Hcl Compare to:
NDC: 50580-0280-10
UPC: 350580-280102
UPC No.: 350580280102 Mfg.Item No.:28010

Have a question?

  CALL US FOR THE PRICE

FLEXERIL?
(cyclobenzaprine HCl) Tablets
DRUG DESCRIPTION

Cyclobenzaprine hydrochloride is a white, crystalline tricyclic amine salt with the empirical formula C20H21N?HCl and a molecular weight of 311.9. It has a melting point of 217?C, and a pKa of 8.47 at 25?C. It is freely soluble in water and alcohol, sparingly soluble in isopropanol, and insoluble in hydrocarbon solvents.

FLEXERIL 5 mg (Cyclobenzaprine HCl) is supplied as a 5 mg tablet for oral administration. FLEXERIL 10 mg (Cyclobenzaprine HCl) is supplied as a 10 mg tablet for oral administration.

FLEXERIL tablets contain the following inactive ingredients: hydroxypropyl cellulose, hydroxypropyl methylcellulose, iron oxide, lactose, magnesium stearate, starch, and titanium dioxide. FLEXERIL 5 mg tablets also contain Yellow D&C #10 Aluminum Lake HT, and Yellow FD&C #6 Aluminum Lake.

INDICATIONS

FLEXERIL is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, limitation of motion, and restriction in activities of daily living.

FLEXERIL should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted.

FLEXERIL has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy.

Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis.

The following list of adverse reactions is based on the experience in 473 patients treated with FLEXERIL 10 mg in additional controlled clinical studies, 7607 patients in the post-marketing surveillance program, and reports received since the drug was marketed. The overall incidence of adverse reactions among patients in the surveillance program was less than the incidence in the controlled clinical studies.